Literature DB >> 2508054

Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition.

T Campfield1, G Braden.   

Abstract

Renal calcifications have been described in very low birth weight (VLBW) infants, and diuretic drug-associated hypercalciuria is believed to play a role in the pathogenesis of this lesion. Hyperoxaluria is an important cause of renal stone formation in children and adults. Because parenteral nutrition solutions contain the oxalate precursors ascorbate and glycine, the relationship between total parenteral nutrition administration and oxalate excretion in VLBW infants was examined. Administration of approximately 0.5 g of total parenteral nutrition protein per kilogram per day to VLBW infants was associated with an increased urinary oxalate concentration and an increased urinary oxalate to creatinine ratio, when compared with VLBW infants receiving a glucose and electrolyte solution. A further increase in urinary oxalate concentration and oxalate to creatinine ratio was noted when total parenteral nutrition protein was increased to approximately 1.5 g of protein per kilogram per day. In VLBW infants who receive total parenteral nutrition, elevated urinary oxalate concentrations may develop and may be a factor in the pathogenesis of nephrocalcinosis in these infants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508054

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Nephrocalcinosis in preterm babies.

Authors:  A Narendra; M P White; H A Rolton; Z I Alloub; G Wilkinson; J H McColl; J Beattie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

2.  Urinary oxalate and glycolate excretion in healthy infants and children.

Authors:  E P Leumann; A Dietl; A Matasovic
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  The incidence of renal calcification in preterm infants.

Authors:  A Short; R W Cooke
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

4.  Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course.

Authors:  Jeanne Fayard; Pierre Pradat; Sylvie Lorthois; Justine Bacchetta; Jean-Charles Picaud
Journal:  Pediatr Nephrol       Date:  2022-03-28       Impact factor: 3.651

5.  Urinary saturation and nephrocalcinosis in preterm infants: effect of parenteral nutrition.

Authors:  B Hoppe; A Hesse; T Neuhaus; S Fanconi; I Forster; N Blau; E Leumann
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

Review 6.  Hereditary causes of kidney stones and chronic kidney disease.

Authors:  Vidar O Edvardsson; David S Goldfarb; John C Lieske; Lada Beara-Lasic; Franca Anglani; Dawn S Milliner; Runolfur Palsson
Journal:  Pediatr Nephrol       Date:  2013-01-20       Impact factor: 3.714

7.  Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula.

Authors:  Vasilios I Giapros; Athanasios L Papaloukas; Anna S Challa; Panagiotis D Nikolopoulos; Constantine G Tsampoulas; Styliani K Andronikou
Journal:  Eur J Pediatr       Date:  2003-05-16       Impact factor: 3.183

8.  High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone.

Authors:  David J Cranefield; David E Odd; Jane E Harding; Rita L Teele
Journal:  Pediatr Radiol       Date:  2003-11-18

Review 9.  Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review.

Authors:  Wesley Jackson; Genevieve Taylor; David Selewski; P Brian Smith; Sue Tolleson-Rinehart; Matthew M Laughon
Journal:  Matern Health Neonatol Perinatol       Date:  2018-11-19

Review 10.  Nephrocalcinosis in preterm neonates.

Authors:  Eveline A Schell-Feith; Joana E Kist-van Holthe; Albert J van der Heijden
Journal:  Pediatr Nephrol       Date:  2008-09-17       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.